Literature DB >> 12024011

Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation.

Michael Leitges1, Kerstin Gimborn, Winfried Elis, Janet Kalesnikoff, Michael R Hughes, Gerald Krystal, Michael Huber.   

Abstract

Regulation of mast cell degranulation is dependent on the subtle interplay of cellular signaling proteins. The Src homology 2 (SH2) domain-containing inositol-5'-phosphatase (SHIP), which acts as the gatekeeper of degranulation, binds via both its SH2 domain and its phosphorylated NPXY motifs to the adapter protein Shc via the latter's phosphorylated tyrosines and phosphotyrosine-binding domain, respectively. This theoretically leaves Shc's SH2 domain available to bind proteins, which might be part of the SHIP/Shc complex. In a search for such proteins, protein kinase C-delta (PKC-delta) was found to coprecipitate in mast cells with Shc and to interact with Shc's SH2 domain following antigen or pervanadate stimulation. Phosphorylation of PKC-delta's Y(332), most likely by Lyn, was found to be responsible for PKC-delta's binding to Shc's SH2 domain. Using PKC-delta(-/-) bone marrow-derived mast cells (BMMCs), we found that the antigen-induced tyrosine phosphorylation of Shc was similar to that in wild-type (WT) BMMCs while that of SHIP was significantly increased. Moreover, increased translocation of PKC-delta to the membrane, as well as phosphorylation at T505, was observed in SHIP(-/-) BMMCs, demonstrating that while PKC-delta regulates SHIP phosphorylation, SHIP regulates PKC-delta localization and activation. Interestingly, stimulation of PKC-delta(-/-) BMMCs with suboptimal doses of antigen yielded a more sustained calcium mobilization and a significantly higher level of degranulation than that of WT cells. Altogether, our data suggest that PKC-delta is a negative regulator of antigen-induced mast cell degranulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12024011      PMCID: PMC133855          DOI: 10.1128/MCB.22.12.3970-3980.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.

Authors:  G Baumann; D Maier; F Freuler; C Tschopp; K Baudisch; J Wienands
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

2.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.

Authors:  J E Damen; L Liu; P Rosten; R K Humphries; A B Jefferson; P W Majerus; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

3.  Syk-dependent phosphorylation of Shc. A potential link between FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2.

Authors:  B Jabril-Cuenod; C Zhang; A M Scharenberg; R Paolini; R Numerof; M A Beaven; J P Kinet
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

Review 4.  Signal transduction by Fc receptors: the Fc epsilon RI case.

Authors:  M A Beaven; H Metzger
Journal:  Immunol Today       Date:  1993-05

5.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.

Authors:  Z Songyang; K L Carraway; M J Eck; S C Harrison; R A Feldman; M Mohammadi; J Schlessinger; S R Hubbard; D P Smith; C Eng
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

6.  Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor.

Authors:  J E Damen; A L Mui; L Puil; T Pawson; G Krystal
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

7.  Isolation and characterization of delta-subspecies of protein kinase C from rat brain.

Authors:  K Ogita; S Miyamoto; K Yamaguchi; H Koide; N Fujisawa; U Kikkawa; S Sahara; Y Fukami; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Identification of tyrosine 187 as a protein kinase C-delta phosphorylation site.

Authors:  W Li; X H Chen; C A Kelley; M Alimandi; J Zhang; Q Chen; D P Bottaro; J H Pierce
Journal:  J Biol Chem       Date:  1996-10-18       Impact factor: 5.157

9.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.

Authors:  Z Songyang; S E Shoelson; J McGlade; P Olivier; T Pawson; X R Bustelo; M Barbacid; H Sabe; H Hanafusa; T Yi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

10.  Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells.

Authors:  K Ozawa; Z Szallasi; M G Kazanietz; P M Blumberg; H Mischak; J F Mushinski; M A Beaven
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

View more
  47 in total

Review 1.  Emerging and diverse roles of protein kinase C in immune cell signalling.

Authors:  Seng-Lai Tan; Peter J Parker
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

2.  Regulation of mast cell survival and function by tuberous sclerosis complex 1.

Authors:  Jinwook Shin; Hongjie Pan; Xiao-Ping Zhong
Journal:  Blood       Date:  2012-02-23       Impact factor: 22.113

Review 3.  Protein kinase C mechanisms that contribute to cardiac remodelling.

Authors:  Alexandra C Newton; Corina E Antal; Susan F Steinberg
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

Review 4.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

5.  Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.

Authors:  Pei-Chih Lee; Yueh-Fu Fang; Hirohito Yamaguchi; Wei-Jan Wang; Tse-Ching Chen; Xuan Hong; Baozhen Ke; Weiya Xia; Yongkun Wei; Zhengyu Zha; Yan Wang; Han-Pin Kuo; Chih-Wei Wang; Chih-Yen Tu; Chia-Hung Chen; Wei-Chien Huang; Shu-Fen Chiang; Lei Nie; Junwei Hou; Chun-Te Chen; Longfei Huo; Wen-Hao Yang; Rong Deng; Katsuya Nakai; Yi-Hsin Hsu; Shih-Shin Chang; Tai-Jan Chiu; Jun Tang; Ran Zhang; Li Wang; Bingliang Fang; Ting Chen; Kwok-Kin Wong; Jennifer L Hsu; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2018-12-10       Impact factor: 31.743

6.  Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.

Authors:  Suresh Selvaraj Palaniyandi; Koichi Inagaki; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2008-09-04       Impact factor: 5.000

7.  Phorbol 12-myristate 13-acetate-dependent protein kinase C delta-Tyr311 phosphorylation in cardiomyocyte caveolae.

Authors:  Vitalyi O Rybin; Jianfen Guo; Zoya Gertsberg; Steven J Feinmark; Susan F Steinberg
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

8.  Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release.

Authors:  Hye Sun Kuehn; Michael A Beaven; Hong-Tao Ma; Mi-Sun Kim; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Signal       Date:  2008-01-22       Impact factor: 4.315

9.  Granzyme D is a novel murine mast cell protease that is highly induced by multiple pathways of mast cell activation.

Authors:  Elin Rönnberg; Gabriela Calounova; Bengt Guss; Anders Lundequist; Gunnar Pejler
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

10.  14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival.

Authors:  Emma F Barry; Fernando A Felquer; Jason A Powell; Lisa Biggs; Frank C Stomski; Andrea Urbani; Hayley Ramshaw; Peter Hoffmann; Matthew C Wilce; Michele A Grimbaldeston; Angel F Lopez; Mark A Guthridge
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.